Apalutamide

Chemical formula: C₂₁H₁₅F₄N₅O₂S  Molecular mass: 477.44 g/mol  PubChem compound: 24872560

Therapeutic indications

Apalutamide is indicated for:

Non-metastatic castration-resistant prostate cancer (nmCRPC)

Population group: men, only adults (18 years old or older)

Apalutamide is indicated in adult men for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Metastatic hormone-sensitive prostate cancer (mHSPC)

Population group: men, only adults (18 years old or older)

Apalutamide is indicated in adult men for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Apalutamide is contraindicated in the following cases:

Pregnancy

Pregnancy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.